Charles G. Phillips III, Director at NovoCure Ltd (NVCR), sold 166,600 shares at $52.09 ($8.7M) on 2019-05-29, disclosed to the SEC on 2019-05-31.
Open-market sale of $8.7M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.08 | 22,200 | $1.2M | 13.3% |
| 2 | $52.09 | 16,326 | $850K | 9.8% |
| 3 | $52.09 | 47,080 | $2.5M | 28.2% |
| 4 | $52.09 | 47,080 | $2.5M | 28.2% |
| 5 | $52.09 | 16,326 | $850K | 9.8% |
| 6 | $52.82 | 1,400 |
| $74K |
| 0.9% |
| 7 | $52.84 | 2,920 | $154K | 1.8% |
| 8 | $52.84 | 2,920 | $154K | 1.8% |
| 9 | $52.96 | 5,174 | $274K | 3.2% |
| 10 | $52.96 | 5,174 | $274K | 3.2% |
| Total | $52.17 avg | 166,600 | $8.7M | 100% |
| Filing → |
| NVCR | SELL | 2018-05-30 | $1.5M | — | Filing → |